Navigation Links
FDA Faulted for Stance on Chemical in Plastics
Date:10/31/2008

BPA widely used in baby bottles, food containers; has been linked to diabetes, heart disease

FRIDAY, Oct. 31 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel agreed Friday that the agency had erred in August when it said that a chemical widely used in baby bottles and other plastic packaging for foods and beverages posed no health risks.

On Wednesday, a panel of toxicology experts said the FDA hadn't properly assessed the potential health risks posed by the chemical bisphenol A (BPA), which some studies have linked to cancer, diabetes, heart disease and developmental delays in children. The toxicologists said the FDA had relied too heavily on studies funded by the chemical industry to make its decision, and had failed to consider other studies that questioned the safety of BPA.

The panel of toxicologists had been convened by the FDA after the agency ruled that BPA was safe at current exposure levels -- a stance that prompted criticism from some lawmakers and consumer groups.

On Friday, the FDA's Science Board, which consists of scientists from academia, government and industry and advises the FDA commissioner, seconded the toxicologists' concerns about the FDA's August ruling. The issue will now go to FDA Commissioner Dr. Andrew von Eschenbach. It's unclear how the FDA might respond, the Washington Post reported.

"Let me be clear: There's no shame for having" your hypothesis disproved, von Eschenbach said during Friday's session, referring to BPA without mentioning it by name, the Dow Jones news service reported.

The FDA's position on BPA has been controversial because it contradicted more than 100 studies, as well as a finding by the U.S. National Toxicology Program, that there was "some concern" that BPA may affect the brain and behavioral development in fetuses, infants and small children, the Post said.

Norris Alderson, associate commissioner for science at the FDA, told Dow Jones that the agency will probably start research early in 2009 to determine the toxic effects of BPA on babies less than 1 month old. Babies are considered the most susceptible group to BPA's effects. It's unclear when those studies would be done, the news service said.

In September, a study published in the Journal of the American Medical Association said that people with high levels of BPA were more likely to have heart disease, including heart attack, or diabetes. High BPA levels increased the risk for these diseases by 39 percent, the researchers reported.

Speaking at Friday's hearing, Steven G. Hentges, of the American Chemistry Council's Polycarbonate/BPA Global Group, said: "The Science Board is receiving many diverse viewpoints on bisphenol A. But the common ground we all share is a commitment to do what's right to protect the health and safety of American consumers -- adults and children alike."

Hentges called the FDA's August draft assessment "consistent with the conclusions of other scientific and government bodies worldwide, such as the European Food Safety Authority, Health Canada, the European Union, and NSF International, all of which completed or updated their assessments this year. We rely on their conclusions, which are that polycarbonate plastic and epoxy resins are safe for use in food contact applications."

Earlier this month, Canada moved to ban plastic baby bottles containing BPA. Several U.S. states are considering restricting BPA use.

More information

To learn more about BPA, visit Environment California.



SOURCES: American Chemistry Council, news release, Oct. 31, 2008; Washington Post; Dow Jones


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Fat on chest and upper back increases risk of insulin resistance
2. Mailman School of Public Health study examines link between racial discrimination and substance use
3. Increased distance to physician associated with thicker skin cancer at diagnosis
4. USAID Provides Additional Wildfire Assistance to Greece
5. PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building
6. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. HHS Provides Over $131 Million In Energy Assistance
9. Free Prescription Drug Program Uses Internet to Deliver Cards - Offers Assistance to Uninsured
10. AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
11. Altarum Wins $7 Million Contract to Provide Technical Assistance to the Access to Recovery Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: